2 of the Cheapest Stocks in Biotech

Biotech is, without question, the biggest roll-of-the-dice industry you can choose to invest in.

Over 90% of publicly traded biotech stocks are expected to lose money in 2017, and the vast majority of discovery, preclinical, and clinical studies end in failure. In fact, Medscape suggested some years back that just one out of every 5,000 to 10,000 drugs examined in preclinical trials will ever make it to pharmacy shelves.

Back to news